ArticleThe Journal of clinical investigation2014

BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.

Niuscha Yaktapour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.